Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Elizabeth M. Gore MD

Elizabeth M. Gore MD

Professor

Institution: Medical College of Wisconsin
Department: Radiation Oncology
Program: Clinical

Member of the Cancer Center
Member of the Cardiovascular Center


Publications

  • Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937. (Gore EM, Hu C, Sun AY, Grimm DF, Ramalingam SS, Dunlap NE, Higgins KA, Werner-Wasik M, Allen AM, Iyengar P, Videtic GMM, Hales RK, McGarry RC, Urbanic JJ, Pu AT, Johnstone CA, Stieber VW, Paulus R, Bradley JD) J Thorac Oncol 2017 Oct;12(10):1561-1570 PMID: 28648948 PMCID: PMC5610652 06/27/2017
  • Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839. (Edelman MJ, Hu C, Le QT, Donington JS, D'Souza WD, Dicker AP, Loo BW, Gore EM, Videtic GMM, Evans NR, Leach JW, Diehn M, Feigenberg SJ, Chen Y, Paulus R, Bradley JD) J Thorac Oncol 2017 Sep;12(9):1413-1420 PMID: 28629896 PMCID: PMC5594738 06/21/2017
  • Early Assessment of Treatment Responses During Radiation Therapy for Lung Cancer Using Quantitative Analysis of Daily Computed Tomography. (Paul J, Yang C, Wu H, Tai A, Dalah E, Zheng C, Johnstone C, Kong FM, Gore E, Li XA) Int J Radiat Oncol Biol Phys 2017 Jun 01;98(2):463-472 PMID: 28463166 05/04/2017
  • Technical Note: Is bulk electron density assignment appropriate for MRI-only based treatment planning for lung cancer? (Prior P, Chen X, Gore E, Johnstone C, Li XA) Med Phys 2017 Jul;44(7):3437-3443 PMID: 28391596 04/10/2017
  • Self-Expanding Metal Stents Improve Swallowing and Maintain Nutrition During Neoadjuvant Therapy for Esophageal Cancer. (Smith ZL, Gonzaga JE, Haasler GB, Gore EM, Dua KS) Dig Dis Sci 2017 Jun;62(6):1647-1656 PMID: 28391413 04/10/2017
  • SU-F-J-162: Is Bulky Electron Density Assignment Appropriatefor MRI-Only Based Treatment Planning for Lung Cancer? (Prior P, Chen X, Johnstone C, Gore E, Li X) Med Phys 2016 Jun;43(6):3445 PMID: 28046762 01/04/2017
  • SU-F-R-54: CT-Texture Based Early Tumor Treatment Response Assessment During Radiation Therapy Delivery: Small Cell Versus Non-Small Cell Lung Cancers. (Paul J, Gore E, Li X) Med Phys 2016 Jun;43(6):3385 PMID: 28048179 01/04/2017
  • Management of independent motion between multiple targets in lung cancer radiation therapy. (Liu F, Tai A, Ahunbay E, Gore E, Johnstone C, Li XA) Pract Radiat Oncol 2017 Jan - Feb;7(1):26-34 PMID: 27742559 10/16/2016
  • Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129. (Xiao C, Zhang Q, Nguyen-Tân PF, List M, Weber RS, Ang KK, Rosenthal D, Filion EJ, Kim H, Silverman C, Raben A, Galloway T, Fortin A, Gore E, Winquist E, Jones CU, Robinson W, Raben D, Le QT, Bruner D) Int J Radiat Oncol Biol Phys 2017 Mar 15;97(4):667-677 PMID: 27727063 PMCID: PMC5266672 10/12/2016
  • Patient-Reported Outcomes (PROs) in NRG Oncology/RTOG 0436: A Phase 3 Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Esophageal Cancer Treated Without Surgery. (Kachnic LA, Moughan J, Suntharalingam M, Ilson DH, Konski AA, Burrows W, Anker C, Ad VB, Thakrar HV, Hayes JP, Gore EM, Kavadi VS, Komaki RU, Raben A, Giguere JK, Pollock J, Greenberger JS, Videtic GM, Roof KS, Watkins Bruner D) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):S31 PMID: 27675900 09/28/2016
  • Quantitative Computed Tomography for Tumor Response Assessment During Radiation Therapy for Lung Cancer. (Paul J, Gore EM, Li A) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):S193 PMID: 27675756 09/28/2016
  • Outcome Analysis of Treatment in Stage IIA, T3N0 Rectal Adenocarcinoma in the Veterans Health Administration (VHA). (Hall WA, Lans D, Arce-Lara C, Kelley MJ, Santana-Davila R, Marcus DM, Tsai S, Ridolfi T, Erickson BA, Gore EM) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):E186 PMID: 27674006 09/28/2016
  • Early Cardiotoxicity in Thoracic Radiation Therapy for Lung and Esophageal Cancer. (Borkenhagen J, Rapp C, Klawikowski S, Rein LE, Gore EM) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):E428 PMID: 27674665 09/28/2016
  • Risk Factors for Early Radiation-Induced Cardiotoxicity in Lung and Esophageal Cancer. (Rapp C, Borkenhagen J, Klawikowski S, Rein LE, Gore EM) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):E429-E430 PMID: 27674667 09/28/2016
  • Early Treatment Response Assessment Based on Computed Tomography HU Histogram Feature in the Periphery of Lung Tumors. (Lim SN, Chen X, Gore EM, Li A) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):E647-E648 PMID: 27675255 09/28/2016
  • Impact of Incidental Cardiac Radiation on Cardiopulmonary Toxicity and Survival for Locally Advanced Non-Small Cell Lung Cancer: Reanalysis of NRG Oncology/RTOG 0617 With Centrally Contoured Cardiac Structures. (Gore EM, Hu C, Ad VB, Robinson CG, Wheatley MD, Bogart JA, Garces Y, Kavadi VS, Narayan S, Iyengar P, Witt JS, Welsh JW, Koprowski CD, Larner JM, Bradley JD) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):S129-S130 PMID: 27675596 09/28/2016
  • Prophylactic cranial irradiation for patients with lung cancer. (Péchoux CL, Sun A, Slotman BJ, De Ruysscher D, Belderbos J, Gore EM) Lancet Oncol 2016 Jul;17(7):e277-e293 PMID: 27396646 07/12/2016
  • Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01. (Mak RH, Hunt D, Efstathiou JA, Heney NM, Jones CU, Lukka HR, Bahary JP, Patel M, Balogh A, Nabid A, Leibenhaut MH, Hamstra DA, Roof KS, Jeffrey Lee R, Gore EM, Sandler HM, Shipley WU) Urol Oncol 2016 Oct;34(10):430.e1-7 PMID: 27381895 PMCID: PMC5035191 07/07/2016
  • An analysis of tumor control probability of stereotactic body radiation therapy for lung cancer with a regrowth model. (Tai A, Liu F, Gore E, Li XA) Phys Med Biol 2016 05 21;61(10):3903-13 PMID: 27117498 04/28/2016
  • Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08. (Voog JC, Paulus R, Shipley WU, Smith MR, McGowan DG, Jones CU, Bahary JP, Zeitzer KL, Souhami L, Leibenhaut MH, Rotman M, Husain SM, Gore E, Raben A, Chafe S, Sandler HM, Efstathiou JA) Eur Urol 2016 Feb;69(2):204-10 PMID: 26362090 PMCID: PMC4784682 09/13/2015
  • SU-E-J-134: Optimizing Technical Parameters for Using Atlas Based Automatic Segmentation for Evaluation of Contour Accuracy Experience with Cardiac Structures From NRG Oncology/RTOG 0617. (Yu J, Gong Y, Bar-Ad V, Giaddui T, Hu C, Gore E, Wheatley M, Witt J, Robinson C, Kong F, Bradley J, Galvin J, Xiao Y) Med Phys 2015 Jun;42(6):3295 PMID: 26127527 07/02/2015
  • SU-E-J-31: Monitor Interfractional Variation of Tumor Respiratory Motion Using 4D KV Conebeam Computed Tomography for Stereotactic Body Radiation Therapy of Lung Cancer. (Tai A, Prior P, Gore E, Johnstone C, Li X) Med Phys 2015 Jun;42(6):3270 PMID: 26127425 07/02/2015
  • A randomized clinical trial evaluating two doses of prophylactic cranial irradiation in complete responder patients with limited-stage SCLC. (Contributor: The Prophylactic Cranial Irradiation (PCI) Collaborative Group (PCI 99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01).) Lancet Oncology 10(5):467-74, 2009. 06/29/2015
  • Using During RT PET to Individualize Adaptive RT for Patients with Stage III NSCLC: A Multicenter Planning Study. Proc of 14th World Conference on Lung Cancer (IASLC); July 3-7, 2011; Amsterdam, Netherlands. (Kong F, Xiao Y, Machtay M, Werner-Wasnik M, Videtic G, Loo B, Wagner H, GORE E, Varlotto J, Faria S, Dilling T, Sun A, Swanson T, Wang L, Galvin J, Ten Haken R, Bradley J.) Journal of Thoracic Oncology 2011;6(6 suppl 2):S834-835. 06/29/2015
  • Prognostic Significance of QOL Deterioration During Early Lung Cancer Survivorship: Secondary Analysis of RTOG 0212 and 0214. Proc of American Society of Clinical Oncology (ASCO) Annual Meeting; June 3-7, 2011; Chicago, IL. (Gondi V, Paulus R, Bruner D, Meyers C, GORE E, Wolfson A, Werner-Wasik M, Choy H, Movsas B.) J Clin Oncol 2011;29(15; May 20 suppl):abstr 6061. 06/29/2015
  • RTOG 0214: A Phase III Comparison of Prophylactic Cranial Irradiation versus Observation in Patients with Locally Advanced Non-Small Cell Lung Cancer: 5 Year Update: Chicago Multidisciplinary Symposium in Thoracic Oncology 2012 Plenary Session presentation Abstr #4; ASTRO Annual Meeting 2012 Oral Presentation. (GORE E, Paulus R, Wong SJ, Sun A, Videtic G, Dutta S, Suntharalingam M, Chen Y, Gaspar L, Choy H.) 06/29/2015
  • Decline in Tested and Patient-reported Cognitive Functioning Following Prophylactic Cranial Irradiation for Lung Cancer: Secondary Analysis of RTOG 0212 and 0214. Amer Soc Thera Rad Onc (ASTRO); October 2-6, 2011; Miami Beach, FL. (Gondi V, Paulus R, Bruner D, Meyers C, GORE E, Wolfson A, Werner-Wasik M, Choy H, Movsas B.) Int J Radiat Oncol Biol Phys 2011;81(2; suppl):S50. 06/29/2015
  • Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408. (Krauss DJ, Hu C, Bahary JP, Souhami L, Gore EM, Chafe SM, Leibenhaut MH, Narayan S, Torres-Roca J, Michalski J, Zeitzer KL, Donavanik V, Sandler H, McGowan DG, Jones CU, Shipley WU) Int J Radiat Oncol Biol Phys 2015 Jul 15;92(4):863-73 PMID: 26104939 PMCID: PMC4480595 06/25/2015
  • Definitive radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline. (Rodrigues G, Choy H, Bradley J, Rosenzweig KE, Bogart J, Curran WJ Jr, Gore E, Langer C, Louie AV, Lutz S, Machtay M, Puri V, Werner-Wasik M, Videtic GM) Pract Radiat Oncol 2015 May-Jun;5(3):141-8 PMID: 25957184 05/10/2015
  • Adjuvant radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline. (Rodrigues G, Choy H, Bradley J, Rosenzweig KE, Bogart J, Curran WJ Jr, Gore E, Langer C, Louie AV, Lutz S, Machtay M, Puri V, Werner-Wasik M, Videtic GM) Pract Radiat Oncol 2015 May-Jun;5(3):149-55 PMID: 25957185 05/10/2015
  • Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910. (Pisansky TM, Hunt D, Gomella LG, Amin MB, Balogh AG, Chinn DM, Seider MJ, Duclos M, Rosenthal SA, Bauman GS, Gore EM, Rotman MZ, Lukka HR, Shipley WU, Dignam JJ, Sandler HM) J Clin Oncol 2015 Feb 01;33(4):332-9 PMID: 25534388 PMCID: PMC4302214 12/24/2014
  • Cisplatin and etoposide versus carboplatin and paclitaxel with concurrent radiotherapy for stage III non-small-cell lung cancer: an analysis of Veterans Health Administration data. (Santana-Davila R, Devisetty K, Szabo A, Sparapani R, Arce-Lara C, Gore EM, Moran A, Williams CD, Kelley MJ, Whittle J) J Clin Oncol 2015 Feb 20;33(6):567-74 PMID: 25422491 PMCID: PMC4322259 11/26/2014
  • Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity. (Nguyen-Tan PF, Zhang Q, Ang KK, Weber RS, Rosenthal DI, Soulieres D, Kim H, Silverman C, Raben A, Galloway TJ, Fortin A, Gore E, Westra WH, Chung CH, Jordan RC, Gillison ML, List M, Le QT) J Clin Oncol 2014 Dec 01;32(34):3858-66 PMID: 25366680 PMCID: PMC4239304 11/05/2014
  • Determination of internal target volume for radiation treatment planning of esophageal cancer by using 4-dimensional computed tomography (4DCT). (Chen X, Lu H, Tai A, Johnstone C, Gore E, Li XA) Int J Radiat Oncol Biol Phys 2014 Sep 01;90(1):102-9 PMID: 25015201 07/13/2014
  • ACR Appropriateness Criteria® pre-irradiation evaluation and management of brain metastases. (Expert Panel on Radiation Oncology-Brain Metastases, Lo SS, Gore EM, Bradley JD, Buatti JM, Germano I, Ghafoori AP, Henderson MA, Murad GJ, Patchell RA, Patel SH, Robbins JR, Robins HI, Vassil AD, Wippold FJ 2nd, Yunes MJ, Videtic GM) J Palliat Med 2014 Aug;17(8):880-6 PMID: 24971478 PMCID: PMC4275774 06/28/2014
  • SU-E-J-190: Characterization of Radiation Induced CT Number Changes in Tumor and Normal Lung During Radiation Therapy for Lung Cancer. (Yang C, Liu F, Tai A, Gore E, Johnstone C, Li X) Med Phys 2014 Jun;41(6):200 PMID: 28036670 06/01/2014
  • MO-C-17A-06: Online Adaptive Re-Planning to Account for Independent Motions Between Multiple Targets During Radiotherapy of Lung Cancer. (Liu F, Tai A, Ahunbay E, Gore E, Johnstone C, Li X) Med Phys 2014 Jun;41(6):415 PMID: 28036924 06/01/2014
  • Review of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task force. (Kunkler IH, Audisio R, Belkacemi Y, Betz M, Gore E, Hoffe S, Kirova Y, Koper P, Lagrange JL, Markouizou A, Pfeffer R, Villa S, SIOG Radiotherapy Task Force) Ann Oncol 2014 Nov;25(11):2134-46 PMID: 24625455 03/15/2014
  • RTOG 0518: randomized phase III trial to evaluate zoledronic acid for prevention of osteoporosis and associated fractures in prostate cancer patients. (Kachnic LA, Pugh SL, Tai P, Smith M, Gore E, Shah AB, Martin AG, Kim HE, Nabid A, Lawton CA) Prostate Cancer Prostatic Dis 2013 Dec;16(4):382-6 PMID: 24080992 PMCID: PMC3830691 10/02/2013
  • SU-D-WAB-03: Online Adaptive Stereotactic Body Radiotherapy for Lung Lesions. (Ahunbay E, Liu F, Bedi M, Gore E, Li X) Med Phys 2013 Jun;40(6Part3):107 PMID: 28519567 06/01/2013
  • Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214. (Gondi V, Paulus R, Bruner DW, Meyers CA, Gore EM, Wolfson A, Werner-Wasik M, Sun AY, Choy H, Movsas B) Int J Radiat Oncol Biol Phys 2013 Jul 15;86(4):656-64 PMID: 23597420 PMCID: PMC4545268 04/20/2013
  • Prostate-specific antigen response after short-term hormone therapy plus external-beam radiotherapy and outcome in patients treated on Radiation Therapy Oncology Group study 9413. (Cury FL, Hunt D, Roach M 3rd, Shipley W, Gore E, Hsu IC, Krisch RE, Seider MJ, Sandler H, Lawton C) Cancer 2013 Jun 01;119(11):1999-2004 PMID: 23504930 PMCID: PMC3663874 03/19/2013
  • Symptomatic radiation pneumonitis in elderly patients receiving thoracic irradiation. (Kharofa J, Gore E) Clin Lung Cancer 2013 May;14(3):283-7 PMID: 23291257 01/08/2013
  • Evaluation and management of elderly patients with lung cancer. (Gore E, Movsas B, Santana-Davila R, Langer C) Semin Radiat Oncol 2012 Oct;22(4):304-10 PMID: 22985813 09/19/2012
  • ACR Appropriateness Criteria® follow-up and retreatment of brain metastases. (Patel SH, Robbins JR, Gore EM, Bradley JD, Gaspar LE, Germano I, Ghafoori P, Henderson MA, Lutz ST, McDermott MW, Patchell RA, Robins HI, Vassil AD, Wippold FJ 2nd, Videtic GM, Expert Panel on Radiation Oncology–Brain Metastases) Am J Clin Oncol 2012 Jun;35(3):302-6 PMID: 22609733 05/23/2012
  • Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lung. (Suntharalingam M, Paulus R, Edelman MJ, Krasna M, Burrows W, Gore E, Wilson LD, Choy H) Int J Radiat Oncol Biol Phys 2012 Oct 01;84(2):456-63 PMID: 22543206 05/01/2012
  • Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy. (Kharofa J, Cohen EP, Tomic R, Xiang Q, Gore E) Int J Radiat Oncol Biol Phys 2012 Sep 01;84(1):238-43 PMID: 22300564 02/04/2012
  • Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. (Curran WJ Jr, Paulus R, Langer CJ, Komaki R, Lee JS, Hauser S, Movsas B, Wasserman T, Rosenthal SA, Gore E, Machtay M, Sause W, Cox JD) J Natl Cancer Inst 2011 Oct 05;103(19):1452-60 PMID: 21903745 PMCID: PMC3186782 09/10/2011
  • Phase I/II trial of a COX-2 inhibitor with limited field radiation for intermediate prognosis patients who have locally advanced non-small-cell lung cancer: radiation therapy oncology group 0213. (Gore E, Bae K, Langer C, Extermann M, Movsas B, Okunieff P, Videtic G, Choy H) Clin Lung Cancer 2011 Mar;12(2):125-30 PMID: 21550559 05/10/2011
  • Muscle endurance, cancer-related fatigue, and radiotherapy in prostate cancer survivors. (Alt CA, Gore EM, Montagnini ML, Ng AV) Muscle Nerve 2011 Mar;43(3):415-24 PMID: 21305569 02/10/2011
  • Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis. (Sun A, Bae K, Gore EM, Movsas B, Wong SJ, Meyers CA, Bonner JA, Schild SE, Gaspar LE, Bogart JA, Werner-Wasik M, Choy H) J Clin Oncol 2011 Jan 20;29(3):279-86 PMID: 21135267 PMCID: PMC3056463 12/08/2010
  • Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214. (Gore EM, Bae K, Wong SJ, Sun A, Bonner JA, Schild SE, Gaspar LE, Bogart JA, Werner-Wasik M, Choy H) J Clin Oncol 2011 Jan 20;29(3):272-8 PMID: 21135270 PMCID: PMC3056462 12/08/2010
  • Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group. (Machtay M, Bae K, Movsas B, Paulus R, Gore EM, Komaki R, Albain K, Sause WT, Curran WJ) Int J Radiat Oncol Biol Phys 2012 Jan 01;82(1):425-34 PMID: 20980108 10/29/2010
  • Non-surgical management of stage I lung cancer. (Gore EM) F1000 Med Rep 2010 Mar 25;2 PMID: 20948862 PMCID: PMC2948386 10/16/2010
  • Stereotactic radiosurgery for the management of brain metastases. (Choong NW, Gore E) N Engl J Med 2010 Aug 05;363(6):592; author reply 592-3 PMID: 20836240 09/14/2010
  • The effects of comorbidity and age on RTOG study enrollment in Stage III non-small cell lung cancer patients who are eligible for RTOG studies. (Firat S, Byhardt RW, Gore E) Int J Radiat Oncol Biol Phys 2010 Dec 01;78(5):1394-9 PMID: 20646856 07/22/2010
  • A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117. (Bradley JD, Moughan J, Graham MV, Byhardt R, Govindan R, Fowler J, Purdy JA, Michalski JM, Gore E, Choy H) Int J Radiat Oncol Biol Phys 2010 Jun 01;77(2):367-72 PMID: 20457350 PMCID: PMC2869096 05/12/2010
  • Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117. (Bradley JD, Bae K, Graham MV, Byhardt R, Govindan R, Fowler J, Purdy JA, Michalski JM, Gore E, Choy H) J Clin Oncol 2010 May 10;28(14):2475-80 PMID: 20368547 PMCID: PMC2881726 04/07/2010
  • Stereotactic body radiation therapy for inoperable early stage lung cancer. (Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone D, Fowler J, Gore E, Choy H) JAMA 2010 Mar 17;303(11):1070-6 PMID: 20233825 PMCID: PMC2907644 03/18/2010
  • RTOG physician and research associate attitudes, beliefs and practices regarding clinical trials: implications for improving patient recruitment. (Ulrich CM, James JL, Walker EM, Stine SH, Gore E, Prestidge B, Michalski J, Gwede CK, Chamberlain R, Bruner DW) Contemp Clin Trials 2010 May;31(3):221-8 PMID: 20215046 03/11/2010
  • Limited-stage small cell lung cancer: current chemoradiotherapy treatment paradigms. (Stinchcombe TE, Gore EM) Oncologist 2010;15(2):187-95 PMID: 20145192 PMCID: PMC3227940 02/11/2010
  • Gated treatment delivery verification with on-line megavoltage fluoroscopy. (Tai A, Christensen JD, Gore E, Khamene A, Boettger T, Li XA) Int J Radiat Oncol Biol Phys 2010 Apr;76(5):1592-8 PMID: 20133069 02/06/2010
  • Tracheoesophageal fistula associated with bevacizumab 21 months after completion of radiation therapy. (Gore E, Currey A, Choong N) J Thorac Oncol 2009 Dec;4(12):1590-1 PMID: 20009916 12/17/2009
  • A phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small cell lung cancer: Initial analysis of Radiation Therapy Oncology Group 0214. (Gore EM, Bae K, Wong S, Bonner J, Sun A, Schild S, Gaspar LE, Bogart J, Werner-Wasik M, Choy H) J Clin Oncol 2009 May 20;27(15_suppl):7506 PMID: 27963476 05/20/2009
  • Brain metastases in very young patients with lung cancer are still brain metastases. (Gore EM) Onkologie 2008 Jun;31(6):297-8 PMID: 18547968 06/13/2008
  • Age is independent of comorbidity influencing patient selection for combined modality therapy for treatment of stage III nonsmall cell lung cancer (NSCLC). (Firat S, Pleister A, Byhardt RW, Gore E) Am J Clin Oncol 2006 Jun;29(3):252-7 PMID: 16755178 06/07/2006
  • Prophylactic cranial irradiation versus observation in stage III non-small-cell lung cancer. (Gore E) Clin Lung Cancer 2006 Jan;7(4):276-8 PMID: 16512983 03/04/2006
  • Technical and dosimetric aspects of respiratory gating using a pressure-sensor motion monitoring system. (Li XA, Stepaniak C, Gore E) Med Phys 2006 Jan;33(1):145-54 PMID: 16485421 02/21/2006
  • RTOG 0214: a phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small cell lung cancer. (Gore E) Clin Adv Hematol Oncol 2005 Aug;3(8):625-6 PMID: 16167048 09/17/2005
  • Phase I results of RTOG L-0117; a phase I/II dose intensification study using 3DCRT and concurrent chemotherapy for patients with Inoperable NSCLC. (Bradley JD, Graham M, Suzanne S, Byhardt R, Govindan R, Fowler J, Purdy J, Michalski J, Gore E, Choy H) J Clin Oncol 2005 Jun;23(16_suppl):7063 PMID: 27944518 06/01/2005
  • Evidence-based review of three-dimensional conformal radiotherapy for localized prostate cancer: an ASTRO outcomes initiative. (Morris DE, Emami B, Mauch PM, Konski AA, Tao ML, Ng AK, Klein EA, Mohideen N, Hurwitz MD, Fraas BA, Roach M 3rd, Gore EM, Tepper JE) Int J Radiat Oncol Biol Phys 2005 May 01;62(1):3-19 PMID: 15850897 04/27/2005
  • Celecoxib and radiation therapy in non-small-cell lung cancer. (Gore E) Oncology (Williston Park) 2004 Dec;18(14 Suppl 14):10-4 PMID: 15685827 02/03/2005
  • Non-small cell lung cancer and central nervous system metastases: should we be using prophylactic cranial irradiation? (Gore E, Choy H) Semin Radiat Oncol 2004 Oct;14(4):292-7 PMID: 15558503 11/24/2004
  • Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. (Garden AS, Harris J, Vokes EE, Forastiere AA, Ridge JA, Jones C, Horwitz EM, Glisson BS, Nabell L, Cooper JS, Demas W, Gore E) J Clin Oncol 2004 Jul 15;22(14):2856-64 PMID: 15254053 07/16/2004
  • Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: results of Radiation Therapy Oncology Group trial BR-0018. (Regine WF, Schmitt FA, Scott CB, Dearth C, Patchell RA, Nichols RC Jr, Gore EM, Franklin RL 3rd, Suh JH, Mehta MP) Int J Radiat Oncol Biol Phys 2004 Apr 01;58(5):1346-52 PMID: 15050309 03/31/2004
  • Prophylactic cranial irradiation for patients with locally advanced non-small-cell lung cancer. (Gore EM) Oncology (Williston Park) 2003 Jun;17(6):775-9; discussion 779-80, 784, 787 passim PMID: 12846122 07/09/2003
  • Do "elderly fit" patients have less comorbidity? (Firat S, Gore E, Byhardt RW) Int J Radiat Oncol Biol Phys 2003 Apr 01;55(5):1166-8 PMID: 12654422 03/26/2003
  • Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group. (Firat S, Byhardt RW, Gore E) Int J Radiat Oncol Biol Phys 2002 Oct 01;54(2):357-64 PMID: 12243808 09/24/2002
  • Posttreatment visual acuity in patients treated with episcleral plaque therapy for choroidal melanomas: dose and dose rate effects. (Jones R, Gore E, Mieler W, Murray K, Gillin M, Albano K, Erickson B) Int J Radiat Oncol Biol Phys 2002 Mar 15;52(4):989-95 PMID: 11958893 04/18/2002
  • Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer. (Firat S, Bousamra M, Gore E, Byhardt RW) Int J Radiat Oncol Biol Phys 2002 Mar 15;52(4):1047-57 PMID: 11958901 04/18/2002
  • Pulmonary function changes in long-term survivors of bone marrow transplantation. (Gore EM, Lawton CA, Ash RC, Lipchik RJ) Int J Radiat Oncol Biol Phys 1996 Aug 01;36(1):67-75 PMID: 8823260 08/01/1996
  • Comparison of high dose-rate and low dose-rate dose distributions for vaginal cylinders. (Gore E, Gillin MT, Albano K, Erickson B) Int J Radiat Oncol Biol Phys 1995 Jan 01;31(1):165-70 PMID: 7995748 01/01/1995
  • Last update: 08/03/2017
    jenkins-FCD Prod-132 e0edc266de37dd13c3a3aec79eb87f3c7abc6fa4